The Government of India and Department of Pharmaceuticals has drafted a Pharmaceutical Policy, 2017


eMediNexus    12 February 2018

which is under consideration and is pending approval. HCFI can give its suggestions on the draft policy as one of the policy initiative is one drug one company one and encouraging medical practitioners to prescribe generic name drugs instead of brand names. 

The key objectives of the Policy is to: 

  1. Make essential drugs accessible at affordable prices to the common masses; 
  2. Provide a longer term stable policy environment for the pharmaceutical sector; 
  3. Make India sufficiently self-reliant in end to end indigenous drug manufacturing; 
  4. Ensure world class quality of drugs for domestic consumption & exports; 
  5. Create an environment for R&D to produce innovator drugs; 

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.